Canaria Therapeutics, Inc. — Form D/A
Canaria Therapeutics, Inc. of HUNTSVILLE, AL, a company, filed a Form D amendment with the SEC on 2020-03-04. The offering totals $23K, of which $3K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-04
- Form: D/A
- Accession: 0001754404-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23K
- Amount sold: $3K
- Remaining: $20K
- Investors: 11
- Date of first sale: 2019-07-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-343276
Issuer
- Name: Canaria Therapeutics, Inc.
- CIK: 0001754404
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Phone: 256-327-0566
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| James R Hudson, Jr. | Director | Huntsville, AL |
| Randall W Moreadith | Director | Huntsville, AL |
| Randall W Moreadith | Executive Officer | Huntsville, AL |
| J Milton Harris | Director | Huntsville, AL |
| J Milton Harris | Executive Officer | Huntsville, AL |
| Michael D Bentley | Director | Huntsville, AL |
| Michael D Bentley | Executive Officer | Huntsville, AL |
| Miguel A Loya | Director | Houston, TX |
| Barbara Milton Fisk | Director | Madison, AL |
Other filings by this issuer (4)
More